Elevated CD73 expression levels significantly correlate with shorter overall survival in breast, ovarian, lung, and gastric cancer [37], and have been linked to cancer progression, migration, invasion, metastasis, chemoresistance, and neovascularization processes [13,38,39]. This evidence concerns the gene NT5E and gastric cancer.